Applications of accelerator MS in pediatric drug evaluation

Bioanalysis

Volumn 4, Issue 15, 2012, Pages 1871-1882

  Vuong, L T ^a   Blood, A B ^b   Vogel, J S ^a   Anderson, M E ^c   Goldstein, B ^c  

^a Vitalea Science Inc   (United States)

^b LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

^c MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; URSODEOXYCHOLIC ACID;

ACCELERATOR MASS SPECTROMETRY; BLOOD SAMPLING; CHILD; CHILD SAFETY; CLINICAL TRIAL (TOPIC); DRUG BLOOD LEVEL; DRUG DEVELOPMENT; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FECES LEVEL; DRUG FORMULATION; DRUG LABELING; DRUG MICRODOSE; DRUG RESEARCH; DRUG SAFETY; DRUG SALIVA LEVEL; DRUG SCREENING; DRUG URINE LEVEL; FOOD AND DRUG ADMINISTRATION; HUMAN; ISOTOPE LABELING; MASS SPECTROMETRY; MEDICAL ETHICS; PARENTAL CONSENT; PEDIATRICS; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; RADIATION EXPOSURE; RADIATION HAZARD; REVIEW; SENSITIVITY AND SPECIFICITY; UREA BREATH TEST; VITAMIN METABOLISM;

ADOLESCENT; BIOLOGICAL AVAILABILITY; CARBON RADIOISOTOPES; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; EUROPE; FEMALE; GUIDELINES AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; PREGNANCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84865743377     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.173     Document Type: Review

References (32)

1. Nurturing Children: A History of Pediatrics. Colon AR, Colon PA (Eds). Greenwood, Westport, CT, USA, 201-210 (1999
2. Vollman J, Winau R. Informed consent in human experimentation before the Nuremberg code. Br. Med. J. 313(7070), 1445-1449 (1996 (Pubitemid 26408033)
3. Moll A. Arzliche Ethik. Enke F, Stuttgart, Germany (1902
4. Sass HM. Reichsrundschreiben 1931: Pre-Nuremberg German regulations concerning new therapy and human experimentations. J. Med. Philos. 8, 99-111 (1983
5. Rose K, van den Anker JN. Guide to Paediatric Clinical Research (First Edition). Karger, Berlin, Germany (2007
6. Cottrell S, Goldstein B. Regulatory considerations for study of generic drugs under best pharmaceuticals for children act: NICHD and FDA Collaboration. In: Pediatric Drug Development: Concepts and Applications. Mulberg AE, Silber SA, van den Anker JN (Eds). John Wiley & Sons, Inc. Hoboken, NJ, USA 165-174 (2009
7. Politis P. Transition from the carrot to the stick: The evolution of pharmaceutical regulations concerning pediatric drug testing. Widener Law Review 12, 271-291 (2005
8. Furst-Recktenwald S, Soergel M. Collecting blood and tissue samples in paediatric clinical trials. In: Guide to Paediatric Clinical Research. Rose K, van den Anker J, Karger S (Eds). Basel, Switzerland, 59-64 (2007
9. Vogel JS, Turteltaub KW, Finkel R, Nelson DE. Accelerator mass spectrometry. Anal. Chem. 67, 353A-359A (1995
10. Vogel JS, Love AH. Quantitating isotopic molecular labels with accelerator mass spectrometry. Methods Enzymol. 402, 402-422 (2005 (Pubitemid 43053134)
11. Stuiver M, Polach HA. Reproting of C-14 data-discussion. Radiocarbon 19, 355-363 (1977
12. Vogel JS. Rapid production of graphite without contamination for biomedical AMS. Radiocarbon 34, 344-350 (1992
13. Vuong LT, Lohstroh P, Blood AB, Vasquez H, Vogel JS. Applying 14C-AMS in neonatal research and care. J. Labelled Comp. Rad. V53, 346 (2010
14. Breitkreutz J, Tuleu C, Solomonidou D. Collecting blood and tissue samples in paediatric clinical trials. In: Guide to Paediatric Clinical Research (1st Edition). Rose K, van den Anker JN (Eds). Karger, Berlin, Germany 68 (2007
15. Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union L378, 1-19 (2007
16. Regulation (EC) No 1902/2006 of the European Parliament and of the Council of 20 December 2006 amending Regulation 1901/2006 on medicinal products for paediatric use. Official Journal of the European Union L378, 20-21 (2007
17. European Medicines Agency. ICH Topic E 11: Clinical investigation of medicinal products in the paediatric population. CPMP/ICH/2711/99 (2001
18. World Medical Association. Declaration of Helsinki - ethical principles for medical research involving human subjects (2008
19. Zisowsky J, Krause A, Dingemanse J. Drug development for pediatric populations: Regulatory aspects. Pharmaceutics 2, 364-388 (2010
20. US Department of Health and Human Services, Food and Drug Administration (FDA). Innovation of Stagnation, challenge and opportunity on the critical path to new medicinal products. Critical path report. MD, USA, March (2004
21. Long D, Koren G, James A. Ethics of drug studies in infants: How many samples are required for accurate estimation of pharmacokinetic parameters in neonates? J. Pediatr. 111, 918-921 (1987 (Pubitemid 18019175)
22. DiStefano JJ 3rd. Optimized blood sampling protocols and sequential design of kinetic experiments. Am. J. Physiol. 240, R259-R265 (1981
23. Mucklow JC, Bending MR, Kahn GC, Dollery CT. Drug concentration in saliva. Clin. Pharmacol. Ther. 24, 563-570 (1978 (Pubitemid 9087297)
24. Koren G. Salivary excretion of drugs in children: Theoretical and practical issues in therapeutic drug monitoring. Dev. Pharmacol. Ther. 19, 161-177 (1992 (Pubitemid 23337116)
25. Mucklow JC. The use of saliva in therapeutic drug monitoring. Ther. Drug Monit. 4, 229-247 (1982 (Pubitemid 12054515)
26. Schmidt-Nielsen B. The pH in parotid and mandibular saliva. Acta Physiol. Scand. 11, 104-110 (1946
27. Dawes C, Jenkins GN. The effects of different stimuli on the composition of saliva in man. J. Physiol. 170, 86-100 (1964
28. Leide-Svegborn S, Stenström K, Olofsson M et al. Biokinetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath test. Eur. J. Nucl. Med. 26, 573-580 (1999 (Pubitemid 29263627)
29. Gunnarsson M, Leide-Svegborn S, Stenström K et al. No radiation protection reasons for restrictions on 14C urea breath tests in children. Br. J. Radiol. 75, 982-986 (2002 (Pubitemid 36149763)
30. Chowdhury S, Kumar R, Ganguly NK et al. Effect of vitamin A supplementation on childhood morbidity and mortality. Indian J. Med. Sci. 56, 259-264(2002 (Pubitemid 39663775)
31. Aklamati EK, Mulenga M, Dueker SR et al. Accelerator mass spectrometry can be used to assess vitamin a metabolism quantitatively in boys in a community setting. J. Nutr. 140, 1588-1594 (2010
32. Setchell KD, Galzigna L, O'Connell N, Brunetti G, Tauschel HD. Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk® suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment. Aliment Pharmacol. Ther. 21, 709-721 (2005). (Pubitemid 40468999)